Parathyroid autofluorescence and parathyroid angiography
Topic prioritisation
Pancreas SABR
Oral cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12214]
Long-acting injections of cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12219]
Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154]
Risankizumab for treating moderate to severe plaque psoriasis in people 6 to 17 years [TSID12204]
Rezafungin for preventing invasive fungal infections after an allogeneic blood and marrow transplant [TSID12165]
Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in children 4 to 11 years [TSID12190]
Zanubrutinib for Chronic lymphocytic leukaemia (CLL) or Follicular lymphoma or Marginal zone lymphoma (MZL) or Waldenstrom's macroglobulinaemia [ID12199]
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]
Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]
Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]
Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106
Remimazolam for sedation for people having diagnostic or therapeutic procedures [ID3758]